Carlos Wambier, MD
Dermatology · South Kingstown, RINPI 1679054043
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,625 of the $40,509 with a category attached, or 63.3%. Pfizer accounts for 75.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $22,307 and has fallen 82.9% since, to $3,807 in 2025. Among dermatology clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $562.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$30K
- Incyte Corporation$9K
- AbbVie$314
- Sun Pharmaceutical Industries Inc.$214
- Sanofi$209
- E.r. Squibb & Sons, L.L.C.$126
- plus $279 from 3 others
Across 35 payments — averaging $25,417 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$636K
- UCB SA$221K
- Eli Lilly$33K
What the payments were for
- Consulting fees$10,43026%
- Speaking & faculty fees$25,62563%
- Travel & lodging$1,8525%
- Food & beverage$2,5026%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 32 | $30,383 |
| Incyte Corporation | 17 | $8,985 |
| AbbVie(2 entities) | 8 | $314 |
| Sun Pharmaceutical Industries Inc. | 4 | $214 |
| Sanofi | 4 | $209 |
| E.r. Squibb & Sons, L.L.C. | 3 | $126 |
| Regeneron | 1 | $100 |
| Galderma Laboratories, L.p. | 1 | $99 |
| UCB, Inc. | 2 | $79 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,509 in reported general payments places this provider in the 90th percentile of 61 dermatology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dutasteride | 179 | $7,056 |
| Minoxidil | 168 | $2,521 |
| ValacyclovirValacyclovir Hcl | 19 | $447 |
| Spironolactone | 25 | $375 |
| Ketoconazole | 13 | $228 |
| Pregabalin | 16 | $178 |
Paid to pharmacies, not to this prescriber.
Other dermatology in South Kingstown
- John KellyEast Greenwich$97K
- Helena KuhnProvidence$63K
- Martin WeinstockProvidence$62K
- Farah MoustafaProvidence$51K
- Abrar QureshiProvidence$38K
- David PomerantzPawtucket$25K
- Gary WatermanMiddletown$16K
- Hua ZhouCranston$16K
- Scott HammermanProvidence$9K
- Laura della TorreProvidence$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.